Select Page

PBN: URI dengue fever researcher wins $11M grant

MOSQUITOES CAN CARRY dengue fever, which URI Professor Alan Rothman will study with an $11.4 grant from the National Institutes of Health.
COURTESY WIKIMEDIA COMMONS
MOSQUITOES CAN CARRY dengue fever, which URI Professor Alan Rothman will study with an $11.4 grant from the National Institutes of Health.

PBN Staff Writer

Posted 8/2/13

PROVIDENCE – A researcher of mosquito-borne illness at the University of Rhode Island has received an $11 million grant from the National Institutes of Health to continue his studies, his second largest grant and one of the largest ever for the university, URI announced Friday.

Professor Alan Rothman, who came to URI in 2011 from the University of Massachusetts Medical School in Worcester, Mass., will use the new, $11.4 million grant from NIH to continue his studies of dengue fever, a sometimes deadly disease carried by mosquitoes that infects about 100 million people a year in the tropics and sub-tropics…. FULL PBN ARTICLE HERE.

 

About iCubed

The Institute for Immunology and Informatics (iCubed) was established in 2008 under the leadership of Annie De Groot, M.D. and Denice Spero, Ph.D., as part of the University of Rhode Island’s emerging Biotechnology Program. The Institute maintains offices and laboratory space in the historic Shepard Building as part of URI’s Feintstein Providence Campus.

The Institute applies cutting-edge bioinformatic tools to accelerate the development of treatments and cures for a number of diseases such as hepatitis C, lyme disease and Dengue fever. The Institute also aims to quickly make these tools available to the global research community for the development of vaccines for other infectious diseases.

Anne De Groot, M.D. has received national and international recognition for her innovative “genome–to–vaccine” approach. Denice Spero, Ph.D., a highly experienced drug discovery researcher, has been noted as a “Woman to Watch” by the RI Quarterly and recently received the Providence Business News’ Industry Leadership Award.

iCubed’s research focuses on new and safer vaccines and new methods of predicting and treating adverse immune responses. iCubed supports a wide variety of training efforts that will provide opportunities to teach the next generation the tools for effective vaccine design.  http://www.immunome.org/